EP2117573A4 - Zusammensetzungen und verfahren zur behandlung von ephrinsignalisierung mit cupredoxinen und mutanten davon - Google Patents

Zusammensetzungen und verfahren zur behandlung von ephrinsignalisierung mit cupredoxinen und mutanten davon

Info

Publication number
EP2117573A4
EP2117573A4 EP08727595A EP08727595A EP2117573A4 EP 2117573 A4 EP2117573 A4 EP 2117573A4 EP 08727595 A EP08727595 A EP 08727595A EP 08727595 A EP08727595 A EP 08727595A EP 2117573 A4 EP2117573 A4 EP 2117573A4
Authority
EP
European Patent Office
Prior art keywords
epphine
cuprexodines
mutants
signaling
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08727595A
Other languages
English (en)
French (fr)
Other versions
EP2117573A2 (de
Inventor
Anita Chaudhari
Ananda Chakrabarty
Gupta Tapas Das
Arsenio Fialho
Tohru Yamada
Yonghua Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois at Urbana Champaign
University of Illinois System
Original Assignee
University of Illinois at Urbana Champaign
University of Illinois System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Illinois at Urbana Champaign, University of Illinois System filed Critical University of Illinois at Urbana Champaign
Publication of EP2117573A2 publication Critical patent/EP2117573A2/de
Publication of EP2117573A4 publication Critical patent/EP2117573A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP08727595A 2007-01-11 2008-01-11 Zusammensetzungen und verfahren zur behandlung von ephrinsignalisierung mit cupredoxinen und mutanten davon Withdrawn EP2117573A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87980407P 2007-01-11 2007-01-11
PCT/US2008/050892 WO2008086523A2 (en) 2007-01-11 2008-01-11 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof

Publications (2)

Publication Number Publication Date
EP2117573A2 EP2117573A2 (de) 2009-11-18
EP2117573A4 true EP2117573A4 (de) 2011-02-16

Family

ID=39609387

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08727595A Withdrawn EP2117573A4 (de) 2007-01-11 2008-01-11 Zusammensetzungen und verfahren zur behandlung von ephrinsignalisierung mit cupredoxinen und mutanten davon

Country Status (2)

Country Link
EP (1) EP2117573A4 (de)
WO (1) WO2008086523A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023205752A2 (en) * 2022-04-22 2023-10-26 University Of Miami Ephrin ligand mimetic peptides for the treatment of neurodegenerative diseases

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005018662A1 (en) * 2003-08-15 2005-03-03 Board Of Trustees Of The University Of Illinois Use of polypeptides of the cupredoxin family in cancer therapy
WO2007018671A2 (en) * 2005-05-20 2007-02-15 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
US20080221015A1 (en) * 2001-02-15 2008-09-11 Anita Chaudhari Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200700813A1 (ru) * 2004-10-07 2008-10-30 Ананда Чакрабарти Транспортирующие вещества, производные купредоксина и способы их применения

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080221015A1 (en) * 2001-02-15 2008-09-11 Anita Chaudhari Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
WO2005018662A1 (en) * 2003-08-15 2005-03-03 Board Of Trustees Of The University Of Illinois Use of polypeptides of the cupredoxin family in cancer therapy
WO2007018671A2 (en) * 2005-05-20 2007-02-15 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHAUDHARI ANITA ET AL: "Cupredoxin-cancer interrelationship: Azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth", BIOCHEMISTRY, vol. 46, no. 7, February 2007 (2007-02-01), pages 1799 - 1810, XP002613162, ISSN: 0006-2960 *
KOOLPE M ET AL: "EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, INC, US, vol. 280, no. 17, 18 February 2005 (2005-02-18), pages 17301 - 17311, XP002390919, ISSN: 0021-9258, DOI: 10.1074/JBC.M500363200 *

Also Published As

Publication number Publication date
WO2008086523A2 (en) 2008-07-17
WO2008086523A3 (en) 2008-10-16
EP2117573A2 (de) 2009-11-18

Similar Documents

Publication Publication Date Title
BRPI0817271A2 (pt) Método de tratamento da doença de parkinson e outros distúrbios relacionados
PT1881823E (pt) Composições e métodos para o tratamento de transtornos oculares
WO2010088518A3 (en) Heterocyclic modulators of gpr119 for treatment of disease
ES2764480T8 (es) Composiciones de combinación para tratar la enfermedad de Alzheimer y trastornos relacionados con zonisamida y acamprosato
EP1893216A4 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
MX2009013990A (es) Metodos para tratar enfermedades y trastornos mediados por serotonina.
EP1874286A4 (de) Verfahren und zusammensetzungen zur behandlung von angstzuständen
ZA201000991B (en) Pharmaceutical compositions and methods of treating dry eye disorders
EP2144612A4 (de) Verfahren und zusammensetzungen zur behandlung von erkrankungen und leiden in zusammenhang mit der mitochondrienfunktion
EP2297341A4 (de) Verfahren und zusammensetzungen zur behandlung von morbus huntington
BRPI0810561A2 (pt) métodos e composições para tratar e monitorar tratamento de desordens associadas à il-13.
LT2894165T (lt) Būdai ir kompozicijos, skirti su komplementu susijusių sutrikimų gydymui
WO2010030813A3 (en) Methods for inhibiting ocular angiogenesis
BRPI0818799A2 (pt) Composições para o tratamento da doença de parkinson
SG2014014153A (en) Preventing and/or treatingmetabolic disorders by modulatingthe amount of enterobacteria
EP2268647A4 (de) Verbindungen und zusammensetzungen für den nachweis und die behandlung von morbus alzheimer und verwandten erkrankungen
EP2440061A4 (de) Verfahren zur hemmung, abhaltung, tötung und/oder abwehr von insekten mithilfe simulierter mischungen aus gänsefüssen
EP2427575A4 (de) Verfahren und zusammensetzungen zur diagnose von schilddrüsenleiden
EP2164996A4 (de) Riboswitches sowie verfahren und zusammensetzungen zur verwendung von und mit riboswitches
EP2147437A4 (de) Seeding-replikation
EP2020970A4 (de) Augenbehandlung
EP2368114A4 (de) Vorhersage und vorbeugung von präeklampsie
EP2170340A4 (de) Verfahren und zusammensetzungen zur stimulation der neurogenese und hemmung der neuronalen degeneration mit isothiazolopyrimidinonen
EP2331100A4 (de) Verfahren und kits zur behandlung von clusterkopfschmerzen
EP2328584A4 (de) Behandlung neurologischer erkrankungen mit huperzin

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090728

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ZHU, YONGHUA

Inventor name: FIALHO, ARSENIO

Inventor name: YAMADA, TOHRU

Inventor name: DAS GUPTA, TAPAS

Inventor name: CHAKRABARTY, ANANDA

Inventor name: CHAUDHARI, ANITA

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20110117

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20121009